Advanced Search

    column
    Exploring the Interventional Effect of Yiqi Huoluo Formula on Qi Deficiency and Blood Stasis Syndrome in Rheumatoid Arthritis Rats Based on RANKL/RANK/NF-κB Pathway
    YANG Yuping, WANG Haidong, WANG Pengfei, SONG Jingjing, GAO Yanhua, WANG Yuwei, LU Dongsheng
    2026, 43(17): 2881-2892. DOI: 10.13748/j.cnki.issn1007-7693.20260368
    Abstract PDF
    Mechanism of Resveratrol in Delaying Vascular Endothelial Cell Senescence Based on SRC-NF-κB Signaling Pathway
    LIU Jun’ai, ZHU Huiming, QIAO Li, LIU Mengyu, ZHANG Huixin, WANG Chao
    2026, 43(17): 2893-2904. DOI: 10.13748/j.cnki.issn1007-7693.20260438
    Abstract PDF
    Exploration on the Pharmacodynamic Material Basis and Molecular Mechanism of Guiqi Baizhu Prescription in the Treatment of Uveal Melanoma Based on Weighted Network Pharmacology
    WANG Ruifeng, GUAN Tiantian, WANG Xinyu, SUN Huazheng, LI Chenghao, WANG Yanru, LI Mi, LIU Yongqi, JIN Xiaojie, ZHANG Yuemei
    2026, 43(17): 2905-2918. DOI: 10.13748/j.cnki.issn1007-7693.20251863
    Abstract PDF
    Integrating Network Pharmacology, Molecular Docking and In Vitro Experiments to Explore the Effects and Mechanisms of Costunolide Against Gastric Cancer
    WANG Yubei, LI Jin, ZENG Juntong, MA Huiying, MA Jianlin, ZHAO Qin
    2026, 43(17): 2919-2931. DOI: 10.13748/j.cnki.issn1007-7693.20261301
    Abstract PDF
    Mechanism Investigation of Costunolide in Treating Ulcerative Colitis via the Gut Microbiota-Bile Acid Axis
    MA Jianguo, XU Rongyi, SHAO Junli, XU Jing, FU Yangyang, QI Yan
    2026, 43(17): 2932-2942. DOI: 10.13748/j.cnki.issn1007-7693.20252330
    Abstract PDF
    Mechanism of Schisandrin A Reversing Paclitaxel Resistance in Ovarian Cancer Cells via Regulation of Mitosis
    WANG Hecai, TAN Qimeng, LONG Liang, CHEN Yang, CHEN Qiuhe
    2026, 43(17): 2943-2953. DOI: 10.13748/j.cnki.issn1007-7693.20252357
    Abstract PDF
    Simultaneous Determination of 14 Phenolic Acids and Flavonoids in Huangjiu Based on the Analytical Quality by Design
    DAI Taiyu, ZHAO Mintong, XIE Jiale, LIU Zhen, HU Yinzhou, LU Xiaoyan, GONG Xingchu
    2026, 43(17): 2954-2963. DOI: 10.13748/j.cnki.issn1007-7693.20252575
    Abstract PDF
    Performance Comparison of Kraken2 and Sylph Tools for Detecting Adventitious Agent Contamination in Biological Products Based on Next-Generation Sequencing
    CHEN Weilian, LI Feng, ZHENG Zhouqin, SHEN Hong, CHEN Huan
    2026, 43(17): 2964-2974. DOI: 10.13748/j.cnki.issn1007-7693.20251511
    Abstract PDF
    Screening and Determination of Illegally Added Polypeptide Retatrutide
    SHI Fen, SHU Zhan, WANG Chengshuai, ZHENG Lanjun, HONG Xiao
    2026, 43(17): 2975-2981. DOI: 10.13748/j.cnki.issn1007-7693.20260046
    Abstract PDF
    Rapid Health Technology Assessment of the Bruton Tyrosine Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    LIANG Cuilyu, WANG Peihong, ZHANG Yin
    2026, 43(17): 2982-2991. DOI: 10.13748/j.cnki.issn1007-7693.20252365
    Abstract PDF
    Practice of Full Pharmaceutical Care for an Acute Lymphoblastic Leukemia Pediatric Patient After Chimeric Antigen Receptor T-cell Immunotherapy
    ZENG Yuanyuan, ZHANG Yong, FANG Yongjun
    2026, 43(17): 2992-2997. DOI: 10.13748/j.cnki.issn1007-7693.20260390
    Abstract PDF
    Construction and Empirical Research on Competency Evaluation Index System for Prescription Review Pharmacists Oriented to Intelligent Transformation: Based on the Delphi-AHP-EWM Integrated Model
    WANG Xiaolan, LYU Bo, GE Yi, SHI Aiming
    2026, 43(17): 3001-3008. DOI: 10.13748/j.cnki.issn1007-7693.20252450
    Abstract PDF
    Analysis of the Development Status of Drug Clinical Trial Institutions in Shanghai
    FAN Yulu, SHI Cuiying, SUN Pengyu, TANG Lei, HUANG Lifeng
    2026, 43(17): 3009-3016. DOI: 10.13748/j.cnki.issn1007-7693.20242370
    Abstract PDF
    Research on the Bottlenecks and Solutions for Cultivating High-caliber Traditional Chinese Medicine Talent in Zhejiang Province
    YANG Huirong, CUI Manfei, FAN Xiaohui, ZHANG Xiangnan, WANG Yi, CHEN Zhong
    2026, 43(17): 3017-3022. DOI: 10.13748/j.cnki.issn1007-7693.20252799
    Abstract PDF
    Legal Risks and Preventive Measures of External Dispensing of Medicines by Medical Institutions
    WANG Jianping, ZHOU Jianwei, CAI Tiantian
    2026, 43(17): 3023-3027. DOI: 10.13748/j.cnki.issn1007-7693.20252523
    Abstract PDF
    Research on the Current Status of Registration and Clinical Trials for Class 3 Chemical Drugs in China and Its Implications
    HUA Yanzhao, XIE Jinping, SHAO Rong
    2026, 43(17): 3028-3034. DOI: 10.13748/j.cnki.issn1007-7693.20252675
    Abstract PDF
    Qualitative Study on Refining Clinical Trial Requirements for Class 3 Chemical Drugs in China
    HUA Yanzhao, XIE Jinping, SHAO Rong
    2026, 43(17): 3035-3043. DOI: 10.13748/j.cnki.issn1007-7693.20252676
    Abstract PDF
    Research Progress on Anti-tumor Effects of Active Ingredients from Coicis Semen via Regulating Tumor Microenvironment
    WANG Wenbin, WANG Xinyu, WU Fangping, GU Mancang
    2026, 43(17): 3044-3051. DOI: 10.13748/j.cnki.issn1007-7693.20261346
    Abstract PDF
    Research Progress on the Mechanism of Arsenical Agents Against Melanoma and Their Nanodelivery System
    YU Siying, SUN Shuang, YANG Dayu, GUO Yuyan, LYU Shaowa
    2026, 43(17): 3052-3060. DOI: 10.13748/j.cnki.issn1007-7693.20252269
    Abstract PDF